8-K
filed June 21, 2023, 7:59 PM ET
ticker FEED
CIK 0001326706
other
confidence high
sentiment neutral
materiality 0.15
NanoVibronix stockholders elect eight directors and ratify Marcum LLP as auditor at annual meeting
ENvue Medical, Inc.
- All eight director nominees elected; votes for ranged from 237,243 to 270,624; broker non-votes of 547,860.
- Ratification of Marcum LLP as independent auditor for FY2023 passed: 673,739 for, 153,422 against, 2,547 abstentions.
- Adjournment proposal approved (744,905 for, 82,423 against) but not used as meeting proceeded.
- Meeting held June 21, 2023; record date April 28, 2023; 1,662,377 shares outstanding and entitled to vote.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
ENvue Medical, Inc. shareholders approved Approval of an adjournment of the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of Proposals 1 and 2. at the 2023-06-21 meeting.
- Outcome
- passed
- Meeting
- 2023-06-21
Exact text from the filing
The Company’s stockholders approved Proposal 3. The results of the voting were as follows: For Against Abstentions Broker Non-Votes 744,905 82,423 2,380 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
ENvue Medical, Inc. shareholders approved Election of eight nominees to serve on the Board for a term of one year or until their respective successors are elected and qualified. at the 2023-06-21 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-21
Exact text from the filing
On June 21, 2023, NanoVibronix, Inc. (the “Company”), held its 2023 annual meeting of stockholders (the “Annual Meeting”).
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
ENvue Medical, Inc. shareholders approved Ratification of the appointment of Marcum LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. at the 2023-06-21 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-21
Exact text from the filing
The Company’s stockholders approved Proposal 2. The results of the voting were as follows: For Against Abstentions Broker Non-Votes 673,739 153,422 2,547 0
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.